Advances in Drug Design and Development for Human Therapeutics Using Artificial Intelligence-II

Building on our 2021-2022 Special Issue, "Advances in Drug Design and Development for Human Therapeutics Using Artificial Intelligence [...].Building on our 2021-2022 Special Issue, "Advances in Drug Design and Development for Human Therapeutics Using Artificial Intelligence [...].

Saved in:
Bibliographic Details
Published inBiomolecules (Basel, Switzerland) Vol. 13; no. 12; p. 1735
Main Authors Wei, Dongqing, Peslherbe, Gilles H., Selvaraj, Gurudeeban, Wang, Yanjing
Format Journal Article
LanguageEnglish
Published Switzerland MDPI AG 01.12.2023
Subjects
Amino acids
Artificial intelligence
Computational linguistics
Conflicts of interest
COVID-19
Deep learning
Design
Drug development
Editors
Informatics
Interdisciplinary subjects
Kinases
Language processing
Learning strategies
Machine learning
n/a
Natural language interfaces
Neural networks
Optimization
Peptides
Physics
Proteins
Ribonucleotide reductase
Severe acute respiratory syndrome coronavirus 2
Simulation
Online AccessGet full text
ISSN2218-273X
2218-273X
DOI10.3390/biom13121735

Cover

More Information
Summary:Building on our 2021-2022 Special Issue, "Advances in Drug Design and Development for Human Therapeutics Using Artificial Intelligence [...].Building on our 2021-2022 Special Issue, "Advances in Drug Design and Development for Human Therapeutics Using Artificial Intelligence [...].
Bibliography:SourceType-Scholarly Journals-1
content type line 14
ObjectType-Editorial-2
ObjectType-Commentary-1
content type line 23
ISSN:2218-273X
2218-273X
DOI:10.3390/biom13121735